Magnetic resonance imaging studies typically use standard anatomical atlases for identification and 33 analyses of (patho-)physiological effects on specific brain areas; these atlases often fail to incorporate 34 neuroanatomical alterations that may occur with both age and disease. The present study utilizes Parkinson's 35 disease and age-specific anatomical atlases of the subthalamic nucleus for diffusion tractography, assessing tracts 36 that run between the subthalamic nucleus and a-priori defined cortical areas known to be affected by Parkinson's 37 disease. The results show that the strength of white matter fiber tracts appear to remain structurally unaffected by 38 disease. Contrary to that, Fractional Anisotropy values were shown to decrease in Parkinson's disease patients for 39 connections between the subthalamic nucleus and the pars opercularis of the inferior frontal gyrus, anterior 40 cingulate cortex, the dorsolateral prefrontal cortex and the pre-supplementary motor, collectively involved in 41 preparatory motor control, decision making and task monitoring. While the biological underpinnings of fractional 42 anisotropy alterations remain elusive, they may nonetheless be used as an index of Parkinson's disease. Moreover, 43 we find that failing to account for structural changes occurring in the subthalamic nucleus with age and disease 44 reduce the accuracy and influence the results of tractography, highlighting the importance of using appropriate 45 atlases for tractography. 46 47 Introduction
The six cortical areas were obtained from http://www.rbmars.dds.nl/CBPatlases.htm, created with 138 tractography methods, based on both human and non-human primate neuroanatomy [56] [57] [58] . The separate cortical 139 masks were extracted from MNI152 1mm space. The cortical atlases were thresholded at 25% to minimize the 140 occurrence of over estimating the region during registration procedures, which were achieved with a nonlinear 141 transform from MNI152 1mm to individual b0 space using the previously generated transformation matrices from 142 the anatomical registrations, with a nearest neighbor interpolation and 12 DOF (see Figure 1 ). 176 For more robust measurements, we created an average of each pair of seed-to-target and target-to-seed streamlines 177 [63, 64] To control for spurious tracking, the tracts were thresholded by 10, whereby any voxel containing less 178 than 10 direct samples were excluded from further analyses [64].
180
We calculated the axial diffusivity (AD), fractional anisotropy (FA), and mean diffusivity (MD) of the 181 seed-to-target and target-to-seed paths derived from the tract strength probability density function approach 182 mentioned in the above section. This was achieved by fitting a voxel wise diffusion tensor model with a weighted 183 least squares regression to each subjects' diffusion image using the DTIFIT function from FDT. Each FDT path 184 was thresholded so that only paths with at least 75 samples where included for further analysis to yield a 185 conservative anatomical representation. Then each pair of corresponding paths were combined (seed-to-target and 186 target-to-seed), binarized and averaged per hemisphere. From these normalized FDT paths we extracted the AD, 
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Motion Parameters

219
Additional Bayesian t-tests were conducted to test for differences across groups in each of the directional 220 (x, y, z) translation and rotation parameters, which index how much the subject moves during the MRI. All results 221 were in favour of the null hypothesis (rotation x: BF 10 = 0.51, rotation y: BF 10 = 0.33, BF 10 = 0.25, translation x:
222 BF 10 = 0.40, translation y: BF 10 = 0.34, translation z: BF 10 = 0.49). Accordingly, motion parameters are not 223 included as a covariate in further analyses.
225
Tract Strengths
226
We first set out to test whether there were differences in tract strength between healthy control subjects 227 and PD patients with a mixed effects ANOVA, incorporating subject and hemisphere as random factors (see 228 Figure 3 and table 3) . When using group specific atlases of the STN, the largest model incorporated a main effect 229 of structure and group, without interaction (BF 10 = 2.61e+175), which is 191 times more likely than the model 230 incorporating an interaction term (BF 10 = 1.37e+173). This provides decisive evidence for tract strengths varying 231 with both group and structure, but without an interaction. 232 233 To test whether there were group differences in the white matter composition, we extracted the AD, FA, 248 and MD values of the six different tracts. Separate ANOVAs were run to assess AD, FA, and MD across groups 249 (table 4) . The model with the most evidence for difference in AD included differences across structure and group, 250 but with no interaction (BF 10 = 7.92e+148). For MD, the strongest model incorporated only differences across 251 structure (BF 10 = 5.21e+127).
253
When assessing FA, decisive evidence was found for the model incorporating an interaction between 254 group and structure with a BF 10 of 4.57e+184, which is 4.2 times more likely than the second largest model which 255 includes only main effects of structure and group (BF 10 = 1.06e+184). Post-hoc Bayesian t-tests revealed strong 256 evidence for differences between groups for FA values between STN and POp with a BF 10 of 18.53, with higher 257 FA values for healthy controls than PD patients. Substantial evidence was found for FA values differing across 258 groups between the STN and the ACC (BF 10 = 3.05), which are also higher in healthy controls than PD patients.
259 Decisive evidence was found for the DLPFC (BF 10 = 5.31e+10) and pre-SMA (BF 10 = 68.31) connectivity 260 profiles, again both with higher FA values for healthy controls than PD patients ( Figure 4 
Disease progression with FA
316
The only FA path to show strong evidence of a correlation with disease progression was the DLPFC 317 ipsilateral score (r = 0.364, BF 10 = 16.50), where side of symptom onset and hemisphere were the same. All other 318 results reported either anecdotal or substantial evidence for no correlation between FA and disease progression 319 (table 7) . 320 321 364 FA has been considered as a summary measure of white matter integrity, that is highly sensitive to microstructural 365 changes, but less sensitive to the type of change [101-104], though theoretically, a reduction in FA could be 366 driven by a singular or combination of altered AD, MD, or radial diffusivity.
368
Moreover, white matter consists not only of axons, but oligodendrocytes, astrocytes and microglia and 369 therefore structural changes can affect any of these properties, each of which is associated with a different function 370 [105, 106] . Studies have shown that FA correlates with myelination which is associated with speed conduction, 371 though this is dependent on the formation and remodeling of oligodendrocytes and differentiation of 372 oligodendrocyte precursor cells (OCPs) whose function is to determine the production, length and thickness of 373 internodes and therefore also likely to contribute to the FA signal [107] [108] [109] [110] . Fewer studies have assessed 374 diffusion parameters in relation to astrocytes, though their contribution to FA signals is likely to be significant 375 given their large occupying volume within both grey and white matter [109, 111] .
377
Physiologically, a disruption or structural abnormality occurring anywhere along the axon, for example 378 due to changes in myelination, impaired astrocyte propagation or suboptimal OCP proliferation and 16 379 differentiation, would impede the rate of conduction and transmission between structures and consequently result 380 in functional impairments [112] . Additionally, more widespread changes in myelin and internode plasticity can 381 be driven by region-specific mechanisms [113, 114] . In the case of PD, local signals arising from dopaminergic 382 cell loss with the substania nigra, or the pathological hyperactivity of the STN could drive the observed structural 383 changes in cortico-basal white matter connections. However, due to the complex timeline and microscopic spatial 384 resolution of these neurochemical and anatomical changes, it is currently not possible to identify which process 385 corresponds with in-vivo human dMRI based FA measures.
387
Further, diffusivity has been correlated with partial voluming effects arising from free-water [115] . Free-388 water reflects the presence of water molecules that are not restrained by cellular barriers and therefore do not 389 show a preference for direction, which may be increased in the presence of cellular damage [116] . Thus, the 390 presence of free-water may influence biases on diffusion metrics which can result in a reduction in FA and or an 391 increase in MD [117, 118] . For instance, free-water present in diffusion has been shown to reflect FA changes 392 occurring in other PD affected areas such as the substantia nigra [119, 120] . Additionally, the measure of tract 393 strength was taken via a probability density function (PDF), which despite being shown as a robust assessment, Overall, we found no evidence for any correlation between either tract strengths or FA values with 399 disease progression or medication response. With one exception, we found a positive correlation for FA values 400 within the STN-DLPFC connectivity profile increasing with disease progression when the side of symptom onset 401 was matched with hemisphere. An increased FA indicating restricted diffusion along a single direction is not 402 necessarily compatible with explanations of neurodegenerative processes when assuming a higher FA implies 403 increased myelination and axonal density which usually decrease with disease progression. It may be possible that 404 the increased FA is explained by an attempted compensatory, neuroplasticity mechanism and or functional 405 reorganization rather than a direct neurodegenerative process [122, 123] , or a response to atypical dopaminergic 406 modulation and levodopa intake [124] [125] [126] . Such an adaptive reorganization of structural and functional pathways 407 would, however, occur long before the onset of clinical symptoms, which is not in line with the rather progressed 408 stage of the PD population within this study [73, 75] . We therefore remain speculative as to the explanation of this 18 437 tracts may be used as a biomarker for disease, though the exact biological mechanisms driving these disease 438 specific alterations in FA remain elusive. Regardless, the differences we find are in the connections to cortical 439 areas involved in preparatory motor control, task monitoring and decision making, rather than cortical areas 440 governing motor output. Further, the results indicate that it is recommended to use an atlas that accounts for 441 anatomical changes associated with PD rather than only age matched controls. See the supporting information for 442 a control analysis to support the use of group specific atlases. Future work should focus on the use of higher field 443 strengths, alternative tractography methods and harmonization of techniques used to investigate PD [137, 138] .
444 Until then, we show that using atlases that are specific to your population can aid analysis where UHF MRI and 445 or manual segmentations are not possible.
447
Tractography methods hold great promise for their contribution to identification of disease, differential 448 diagnoses between subtypes of parkinsonian syndromes and the application of DBS [139, 140] . Such applications 449 require assessment of the biological foundations of diffusion metrics and neuroanatomical factors with specific 450 subsets of disease scales used to evaluate presence and severity. 451 452 467 (2012) 
